Using a public dataset (Nephroseq v5, http://v5.nephroseq.org) of gene expression profiles in CKD patients, CD300A expression was significantly higher in patients with CKD due to diabetic nephropathy and focal segmental glomerulosclerosis than in control patients (Figure 7A). This evidence concerns the gene CD300A and chronic kidney disease.